# The Study of microRNA 107 (miRNA 107) and Beta-amyloid Precursor Protein-cleaving Enzyme 1 (BACE1) Messenger Ribonucleic Acid (mRNA) Gene Expression in Cerebrospinal Fluid and Peripheral Blood of Alzheimer's Disease

> **NCT01819545** · — · UNKNOWN · sponsor: **Shanghai Mental Health Center** · enrollment: 300 (estimated)

## Conditions studied

- Alzheimer's Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01819545
- **Lead sponsor:** Shanghai Mental Health Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-01
- **Primary completion:** 2014-07
- **Final completion:** 2015-12
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2014-02-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01819545

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01819545, "The Study of microRNA 107 (miRNA 107) and Beta-amyloid Precursor Protein-cleaving Enzyme 1 (BACE1) Messenger Ribonucleic Acid (mRNA) Gene Expression in Cerebrospinal Fluid and Peripheral Blood of Alzheimer's Disease". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01819545. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*